Sher L Hendrickson

Summary

Affiliation: National Institutes of Health
Country: USA

Publications

  1. ncbi Mitochondrial DNA haplogroups influence lipoatrophy after highly active antiretroviral therapy
    Sher L Hendrickson
    Laboratory of Genomic Diversity, National Cancer Institute, Frederick, MD 21702 1201
    J Acquir Immune Defic Syndr 51:111-6. 2009
  2. ncbi Effect of host genetics on incidence of HIV neuroretinal disorder in patients with AIDS
    Efe Sezgin
    Laboratory of Genomic Diversity, National Cancer Institute, Frederick, MD 21702 1201, USA
    J Acquir Immune Defic Syndr 54:343-51. 2010
  3. ncbi Mitochondrial DNA haplogroups influence AIDS progression
    Sher L Hendrickson
    Laboratory of Genomic Diversity, National Cancer Institute, Frederick, Maryland 21702 1201, USA
    AIDS 22:2429-39. 2008
  4. ncbi Effect of host genetics on the development of cytomegalovirus retinitis in patients with AIDS
    Efe Sezgin
    Laboratory of Genomic Diversity, SAIC Frederick, National Cancer Institute, Frederick, Maryland 21702 1201, USA
    J Infect Dis 202:606-13. 2010
  5. ncbi Genetic variants in nuclear-encoded mitochondrial genes influence AIDS progression
    Sher L Hendrickson
    Laboratory of Genomic Diversity, National Cancer Institute, Frederick, Maryland, USA
    PLoS ONE 5:e12862. 2010
  6. ncbi Genome-wide association study implicates PARD3B-based AIDS restriction
    Jennifer L Troyer
    Laboratory of Genomic Diversity, SAIC Frederick, Inc, Frederick, MD 21702, USA
    J Infect Dis 203:1491-502. 2011
  7. ncbi Mitochondrial haplogroups are associated with risk of neuroretinal disorder in HIV-positive patients
    Sher L Hendrickson
    Laboratory of Genomic Diversity, National Cancer Institute, Frederick, MD 21702 1201, USA
    J Acquir Immune Defic Syndr 53:451-5. 2010
  8. ncbi The principal genetic determinants for nasopharyngeal carcinoma in China involve the HLA class I antigen recognition groove
    Minzhong Tang
    College of Life Science and Bio engineering, Beijing University of Technology, Beijing, China
    PLoS Genet 8:e1003103. 2012
  9. ncbi Host genetic influences on highly active antiretroviral therapy efficacy and AIDS-free survival
    Sher L Hendrickson
    Laboratory of Genomic Diversity, National Cancer Institute, Frederick, MD 21702 1201, USA
    J Acquir Immune Defic Syndr 48:263-71. 2008
  10. ncbi NPHS2 variation in sporadic focal segmental glomerulosclerosis
    Louise M McKenzie
    Laboratory of Genomic Diversity, SAIC Frederick, National Cancer Institute, NCI Frederick, Frederick, Maryland, USA
    J Am Soc Nephrol 18:2987-95. 2007

Collaborators

Detail Information

Publications10

  1. ncbi Mitochondrial DNA haplogroups influence lipoatrophy after highly active antiretroviral therapy
    Sher L Hendrickson
    Laboratory of Genomic Diversity, National Cancer Institute, Frederick, MD 21702 1201
    J Acquir Immune Defic Syndr 51:111-6. 2009
    ..05, OR = 0.52, 95% CI = 0.20 to 1.00). These data suggest that mitochondrial DNA haplogroup may influence the propensity for lipoatrophy in patients receiving nucleoside reverse transcriptase inhibitors...
  2. ncbi Effect of host genetics on incidence of HIV neuroretinal disorder in patients with AIDS
    Efe Sezgin
    Laboratory of Genomic Diversity, National Cancer Institute, Frederick, MD 21702 1201, USA
    J Acquir Immune Defic Syndr 54:343-51. 2010
    ..Clearly, further studies are warrented...
  3. ncbi Mitochondrial DNA haplogroups influence AIDS progression
    Sher L Hendrickson
    Laboratory of Genomic Diversity, National Cancer Institute, Frederick, Maryland 21702 1201, USA
    AIDS 22:2429-39. 2008
    ....
  4. ncbi Effect of host genetics on the development of cytomegalovirus retinitis in patients with AIDS
    Efe Sezgin
    Laboratory of Genomic Diversity, SAIC Frederick, National Cancer Institute, Frederick, Maryland 21702 1201, USA
    J Infect Dis 202:606-13. 2010
    ..The ubiquitous CMV pathogen contains a human interleukin-10 (IL-10) homolog in its genome and utilizes it to evade host immune reactions through an IL-10 receptor mediated immune-suppression pathway...
  5. ncbi Genetic variants in nuclear-encoded mitochondrial genes influence AIDS progression
    Sher L Hendrickson
    Laboratory of Genomic Diversity, National Cancer Institute, Frederick, Maryland, USA
    PLoS ONE 5:e12862. 2010
    ..Mitochondrial pathogenesis occurs in HIV patients and genetically, mitochondrial DNA haplogroups with presumed functional differences have been associated with differential AIDS progression...
  6. ncbi Genome-wide association study implicates PARD3B-based AIDS restriction
    Jennifer L Troyer
    Laboratory of Genomic Diversity, SAIC Frederick, Inc, Frederick, MD 21702, USA
    J Infect Dis 203:1491-502. 2011
    ..Here we used clinically well-characterized subjects from 5 pretreatment HIV/AIDS cohorts for a genome-wide association study to identify gene associations with rate of AIDS progression...
  7. ncbi Mitochondrial haplogroups are associated with risk of neuroretinal disorder in HIV-positive patients
    Sher L Hendrickson
    Laboratory of Genomic Diversity, National Cancer Institute, Frederick, MD 21702 1201, USA
    J Acquir Immune Defic Syndr 53:451-5. 2010
    ..5% vs. 8.9% in patients with vs. without haplogroup J, respectively, P = 0.05). These data suggest that mitochondrial genotype may influence propensity to develop HIV-associated NRD in patients with AIDS...
  8. ncbi The principal genetic determinants for nasopharyngeal carcinoma in China involve the HLA class I antigen recognition groove
    Minzhong Tang
    College of Life Science and Bio engineering, Beijing University of Technology, Beijing, China
    PLoS Genet 8:e1003103. 2012
    ....
  9. ncbi Host genetic influences on highly active antiretroviral therapy efficacy and AIDS-free survival
    Sher L Hendrickson
    Laboratory of Genomic Diversity, National Cancer Institute, Frederick, MD 21702 1201, USA
    J Acquir Immune Defic Syndr 48:263-71. 2008
    ..27; P=0.01). ARG influence after HAART suggests residual HIV-1 replication, and spread continues even in patients successfully suppressing detectable viral RNA...
  10. ncbi NPHS2 variation in sporadic focal segmental glomerulosclerosis
    Louise M McKenzie
    Laboratory of Genomic Diversity, SAIC Frederick, National Cancer Institute, NCI Frederick, Frederick, Maryland, USA
    J Am Soc Nephrol 18:2987-95. 2007
    ..5, P = 0.001). These results indicate that genetic variation or mutation of NPHS2 may play a role in late-onset sporadic FSGS...